Gluten Exorphin A5
Gluten Exorphin A5 is an orally active δ-opioid receptor ligand. Gluten Exorphin A5 exhibits opioid agonist biological activity, analgesic activity, stress-induced analgesia regulatory effects, memory-promoting effects, and non-cytotoxicity. Gluten Exorphin A5 modulates intestinal permeability, can cross in vitro human intestinal epithelial cells via paracellular transport, and resists brush border peptidase hydrolysis. Gluten Exorphin A5 can be used in the research of stress-related processes and cognitive processes.
For research use only. We do not sell to patients.
- CAS No.: 142155-24-6
- Formula: C29H37N5O9
- Molecular Weight:599.63
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Opioid Receptor Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
δ Opioid Receptor/DOR 60 μM (IC50) |
In Vitro
Gluten Exorphin A5 (10-100 μg; 2-6 h) exerts no cytotoxic effect on 70% Caco-2/30% HT-29 co-cultured cells after 2 h or 6 h of incubation[3].
Gluten Exorphin A5 (30 μg; 30 or 120 min) passes through the 70% Caco-2/30% HT-29 intestinal epithelial co-culture layer as an intact peptide, with basolateral recovery ratios accounting for 0.5% and 3% of the apical administered dose, respectively. The Papp reaches 2.06 × 10-6 cm/s at 120 min of exposure[3].
After 2 h of incubation with Gluten Exorphin A5 (30-600 μg; 2 h), the 600 μg concentration increases the viability of 70% Caco2/30% HT-29 co-cultured cells by 20%-30%, while the 30 μg and 150 μg doses exert no significant effects[2].
Gluten Exorphin A5 (30-600 μg; 120 min) reduces the TEER of 70% Caco2/30% HT-29 co-cultured monolayers in a dose-dependent manner. After 120 min of incubation, the 600 μg dose decreases TEER by 30%, while the 30 μg dose shows no significant effect[2].
The Papp of Gluten Exorphin A5 (600 μg; 120 min) across the 70% Caco-2/30% HT-29 intestinal epithelial co-culture layer is 19.53 × 10-6 cm/s; it increases the viability of 70% Caco-2/30% HT-29 co-cultured cells by approximately 20-30%, while 30 μg and 150 μg exert no significant effects[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:70% Caco-2/30% HT-29 human colon adenocarcinoma co-culture
-
Concentration:10 μg, 30 μg, 100 μg
-
Incubation Time:2 h, 6 h
-
Result:Cause a small, statistically non-significant decrease in cell proliferation rate after 6 h incubation compared to control values and 2 h incubation values.
Show no statistically significant differences in cell proliferation rate between different concentrations.
-
Cell Line:70% Caco2/30% HT-29 co-culture cells (post-confluent day 6)
-
Concentration:30 μg, 150 μg, 600 μg
-
Incubation Time:2 h
-
Result:Increased viability by approximately 20-30% at 600 μg; 30 and 150 μg produced no significant effect.
In Vivo
Gluten Exorphin A5 (30 or 300 μg/mouse; intracerebroventricular injection; 5 min prior to stress) inhibits foot shock stress-induced analgesia, while 300 μg/mouse enhances psychosocial stress-induced analgesia, and neither dose affects forced swimming stress-induced analgesia[1].
Gluten Exorphin A5 (30 or 300 mg/kg; p.o.; 5 min before stress) inhibits psychosocial stress-induced analgesia, but does not affect analgesia induced by foot shock or forced swimming stress[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ddY mice (male, 22-28 g)[1]
-
Dosage:30 or 300 μg/mouse
-
Administration:i.c.v.
-
Result:Produced mild dose-dependent antinociception, with a significant effect at 300 μg/mouse.
-
Animal Model:Footshock, forced-swim and socio-psychological stress models[1]
-
Dosage:30 or 300 μg/mouse
-
Administration:i.c.v.; 5 min before stress
-
Result:Suppressed FS-SIA; potentiated PSY-SIA at 300 μg/mouse; did not affect SW-SIA.
-
Animal Model:Footshock, forced-swim and socio-psychological stress models[1]
-
Dosage:30 or 300 mg/kg
-
Administration:p.o.; 5 min before stress
-
Result:Suppressed PSY-SIA but did not affect FS-SIA or SW-SIA.
Chemical Information
-
CAS No. 142155-24-6
-
Molecular Weight 599.63
-
Formula C29H37N5O9
-
Sequence
Gly-Tyr-Tyr-Pro-Thr
-
Sequence Shortening
GYYPT
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Transepithelial/transendothelial electrical resistance assay
TEER measures electrical resistance across epithelial or endothelial monolayers cultured on permeable supports, and the readout reflects ionic conductance through the cell barrier, especially the paracellular pathway regulated by junctional integrity. TEER can be measured without destroying the monolayer and is commonly used before or during transport, permeability, barrier-disruption, and barrier-maturation experiments. TEER values are influenced by biological maturation and technical conditions; reported factors include temperature, medium formulation, passage number, electrode geometry, membrane properties, and junctional length during early monolayer maturation. Therefore, TEER should be interpreted with blank-insert subtraction, area normalization, repeated readings, and, when possible, orthogonal barrier readouts such as FITC-dextran flux or tight-junction staining.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)